TY  - GEN
AU  - Dai,Xiaomeng
AU  - Meng,Jingshu
AU  - Deng,Suke
AU  - Zhang,Lingling
AU  - Wan,Chao
AU  - Lu,Lisen
AU  - Huang,Jing
AU  - Hu,Yan
AU  - Zhang,Zhanjie
AU  - Li,Yan
AU  - Lovell,Jonathan F
AU  - Wu,Gang
AU  - Yang,Kunyu
AU  - Jin,Honglin
TI  - Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel
SN  - 1838-7640
PY  - 2021///0802
KW  - Amino Acid Sequence
KW  - Animals
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Ascites
KW  - etiology
KW  - B7-H1 Antigen
KW  - biosynthesis
KW  - Benzylamines
KW  - Calcium-Calmodulin-Dependent Protein Kinase Type 2
KW  - antagonists & inhibitors
KW  - Cellular Reprogramming Techniques
KW  - Drug Compounding
KW  - Drug Screening Assays, Antitumor
KW  - Female
KW  - Hydrogels
KW  - Immunotherapy
KW  - methods
KW  - Injections, Intraperitoneal
KW  - Liver Neoplasms, Experimental
KW  - complications
KW  - Macrophage Activation
KW  - Male
KW  - Melanoma, Experimental
KW  - immunology
KW  - Melitten
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Mice, Inbred C57BL
KW  - Molecular Targeted Therapy
KW  - Neoplasm Proteins
KW  - Oligopeptides
KW  - Protein Kinase Inhibitors
KW  - Random Allocation
KW  - Recombinant Fusion Proteins
KW  - Sulfonamides
KW  - Tumor Escape
KW  - drug effects
KW  - Tumor-Associated Macrophages
KW  - classification
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.7150/thno.42385
ER  -